IASO DISCOVERY

We are a French biotech specializing in oligonucleotide therapeutics, offering an end-to-end drug discovery platform from design to manufacturing transfer. Our expertise spans ASO, siRNA, miRNA, Decoy across multiple therapeutic areas. With proprietary technologies and flexible collaboration models, we support external partners through fee-for-service or co-development. Focused on innovation and speed, we provide customized solutions to accelerate the development of next-generation therapeutics.